A transactivation-deficient mouse model provides insights into Trp53 regulation and function
10.1038/79152
Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Jimenez, G. S., Nister, M., Stommel, J. M., Beeche, M., Barcarse, E. A., Zhang, X.-Q., O’Gorman, S., & Wahl, G. M. (2000). A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nature Genetics, 26(1), 37–43.

Authors 8
  1. Gretchen S. Jimenez (first)
  2. Monica Nister (additional)
  3. Jayne M. Stommel (additional)
  4. Michelle Beeche (additional)
  5. Erin A. Barcarse (additional)
  6. Xiao-Qun Zhang (additional)
  7. Stephen O'Gorman (additional)
  8. Geoffrey M. Wahl (additional)
References 40 Referenced 152
  1. Ko, L.J. & Prives, C. p53: puzzle and paradigm. Genes Dev. 10, 1054–1072 (1996). (10.1101/gad.10.9.1054) / Genes Dev. by LJ Ko (1996)
  2. Giaccia, A.J. & Kastan, M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973–2983 (1998). (10.1101/gad.12.19.2973) / Genes Dev. by AJ Giaccia (1998)
  3. Attardi, L.D., Lowe, S.W., Brugarolas, J. & Jacks, T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15, 3693–3701 (1996). (10.1002/j.1460-2075.1996.tb00739.x) / EMBO J. by LD Attardi (1996)
  4. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. & Oren, M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9, 2170–2183 (1995). (10.1101/gad.9.17.2170) / Genes Dev. by Y Haupt (1995)
  5. Sabbatini, P., Lin, J., Levine, A.J. & White, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9, 2184–2192 (1995). (10.1101/gad.9.17.2184) / Genes Dev. by P Sabbatini (1995)
  6. Walker, K.K. & Levine, A.J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl Acad. Sci. USA 93, 15335–15340 (1996). (10.1073/pnas.93.26.15335) / Proc. Natl Acad. Sci. USA by KK Walker (1996)
  7. Lee, S., Elenbaas, B., Levine, A. & Griffith, J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013–1020 (1995). (10.1016/S0092-8674(05)80006-6) / Cell by S Lee (1995)
  8. Mummenbrauer, T. et al. p53 Protein exhibits 3′-to-5′ exonuclease activity. Cell 85, 1089–1099 (1996). (10.1016/S0092-8674(00)81309-4) / Cell by T Mummenbrauer (1996)
  9. Sturzbecher, H.W., Donzelmann, B., Henning, W., Knippschild, U. & Buchhop, S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15, 1992–2002 (1996). (10.1002/j.1460-2075.1996.tb00550.x) / EMBO J. by HW Sturzbecher (1996)
  10. Lin, J., Chen, J., Elenbaas, B. & Levine, A.J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235–1246 (1994). (10.1101/gad.8.10.1235) / Genes Dev. by J Lin (1994)
  11. O'Gorman, S., Dagenais, N.A., Qian, M. & Marchuk, Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl Acad. Sci. USA 94, 14602–14607 (1997). (10.1073/pnas.94.26.14602) / Proc. Natl Acad. Sci. USA by S O'Gorman (1997)
  12. Sah, V.P. et al. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10, 175–180 (1995). (10.1038/ng0695-175) / Nature Genet. by VP Sah (1995)
  13. Kussie, P.H. et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948–953 (1996). (10.1126/science.274.5289.948) / Science by PH Kussie (1996)
  14. Kubbutat, M.H., Jones, S.N. & Vousden, K.H. Regulation of p53 stability by Mdm2. Nature 387, 299–303 (1997). (10.1038/387299a0) / Nature by MH Kubbutat (1997)
  15. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296–299 (1997). (10.1038/387296a0) / Nature by Y Haupt (1997)
  16. Juven-Gershon, T. & Oren, M. Mdm2: the ups and downs. Mol. Med. 5, 71–83 (1999). (10.1007/BF03402141) / Mol. Med. by T Juven-Gershon (1999)
  17. McLure, K.G. & Lee, P.W. How p53 binds DNA as a tetramer. EMBO J. 17, 3342–3350 (1998). (10.1093/emboj/17.12.3342) / EMBO J. by KG McLure (1998)
  18. Zauberman, A., Barak, Y., Ragimov, N., Levy, N. & Oren, M. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J. 12, 2799–2808 (1993). (10.1002/j.1460-2075.1993.tb05941.x) / EMBO J. by A Zauberman (1993)
  19. Kapoor, M., Hamm, R., Yan, W., Taya, Y. & Lozano, G. Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene 19, 358–364 (2000). (10.1038/sj.onc.1203300) / Oncogene by M Kapoor (2000)
  20. Bottger, A. et al. Molecular characterization of the hdm2-p53 interaction. J. Mol. Biol. 269, 744–756 (1997). (10.1006/jmbi.1997.1078) / J. Mol. Biol. by A Bottger (1997)
  21. Ljungman, M., Zhang, F., Chen, F., Rainbow, A.J. & McKay, B.C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18, 583–592 (1999). (10.1038/sj.onc.1202356) / Oncogene by M Ljungman (1999)
  22. Roth, J., Dobbelstein, M., Freedman, D.A., Shenk, T. & Levine, A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554–564 (1998). (10.1093/emboj/17.2.554) / EMBO J. by J Roth (1998)
  23. Freedman, D.A. & Levine, A.J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288–7293 (1998). (10.1128/MCB.18.12.7288) / Mol. Cell. Biol. by DA Freedman (1998)
  24. Stommel, J.M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660–1672 (1999). (10.1093/emboj/18.6.1660) / EMBO J. by JM Stommel (1999)
  25. de Stanchina, E. et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434–2442 (1998). (10.1101/gad.12.15.2434) / Genes Dev. by E de Stanchina (1998)
  26. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998). (10.1101/gad.12.15.2424) / Genes Dev. by F Zindy (1998)
  27. Khan, S.K., Moritsugu, J. & Wahl, G.M. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption and ribonucleotide depletion. Proc. Natl Acad. Sci. USA 97, 3266–3271 (2000). (10.1073/pnas.97.7.3266) / Proc. Natl Acad. Sci. USA by SK Khan (2000)
  28. Sherr, C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2991 (1998). (10.1101/gad.12.19.2984) / Genes Dev. by CJ Sherr (1998)
  29. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304–6311 (1991). / Cancer Res. by MB Kastan (1991)
  30. Linke, S.P., Clarkin, K.C., Di Leonardo, A., Tsou, A. & Wahl, G.M. A reversible p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10, 934–947 (1996). (10.1101/gad.10.8.934) / Genes Dev. by SP Linke (1996)
  31. Kern, S.E. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827–830 (1992). (10.1126/science.1589764) / Science by SE Kern (1992)
  32. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847–849 (1993). (10.1038/362847a0) / Nature by SW Lowe (1993)
  33. Clarke, A.R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852 (1993). (10.1038/362849a0) / Nature by AR Clarke (1993)
  34. Wahl, G.M., Linke, S.P., Paulson, T.G. & Huang, L.C. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv. 29, 183–219 (1997). / Cancer Surv. by GM Wahl (1997)
  35. Ford, J.M. & Hanawalt, P.C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl Acad. Sci. USA 92, 8876–8880 (1995). (10.1073/pnas.92.19.8876) / Proc. Natl Acad. Sci. USA by JM Ford (1995)
  36. Tanaka, H. et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404, 42–49 (2000). (10.1038/35003506) / Nature by H Tanaka (2000)
  37. Wang, X.W. et al. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10, 1219–1232 (1996). (10.1101/gad.10.10.1219) / Genes Dev. by XW Wang (1996)
  38. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153–1163 (1991). (10.1016/0092-8674(91)90011-M) / Cell by VL Tybulewicz (1991)
  39. Jimenez, G.S. et al. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400, 81–83 (1999). (10.1038/21913) / Nature by GS Jimenez (1999)
  40. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992) (10.1038/356215a0) / Nature by LA Donehower (1992)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:34 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 4:55 p.m.)
Indexed 1 month, 3 weeks ago (July 1, 2025, 5:41 p.m.)
Issued 24 years, 11 months ago (Sept. 1, 2000)
Published 24 years, 11 months ago (Sept. 1, 2000)
Published Print 24 years, 11 months ago (Sept. 1, 2000)
Funders 0

None

@article{Jimenez_2000, title={A transactivation-deficient mouse model provides insights into Trp53 regulation and function}, volume={26}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/79152}, DOI={10.1038/79152}, number={1}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Jimenez, Gretchen S. and Nister, Monica and Stommel, Jayne M. and Beeche, Michelle and Barcarse, Erin A. and Zhang, Xiao-Qun and O’Gorman, Stephen and Wahl, Geoffrey M.}, year={2000}, month=sep, pages={37–43} }